These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29032303)

  • 1. Current strategies to streamline pharmacotherapy for older adults.
    Schlender JF; Vozmediano V; Golden AG; Rodriguez M; Samant TS; Lagishetty CV; Eissing T; Schmidt S
    Eur J Pharm Sci; 2018 Jan; 111():432-442. PubMed ID: 29032303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Pharmacogenomics: achievements, challenges and prospects, for patients, pharmaceutical industries and healthcare systems".
    Sanoudou D
    Curr Pharm Des; 2010; 16(20):2182-3. PubMed ID: 20459384
    [No Abstract]   [Full Text] [Related]  

  • 3. Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.
    Valdes R; Yin DT
    Clin Lab Med; 2016 Sep; 36(3):447-59. PubMed ID: 27514461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Pharmacogenomics in Precision Medicine.
    Cascorbi I
    Clin Pharmacol Ther; 2018 May; 103(5):732-735. PubMed ID: 29660122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomic biomarkers for personalized cancer treatment.
    Rodríguez-Antona C; Taron M
    J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
    Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
    Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized Medicine: Pharmacogenomics and Drug Development.
    Mirsadeghi S; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):150-165. PubMed ID: 28282716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness.
    Linares OA; Daly D; Linares AD; Stefanovski D; Boston RC
    Pain Med; 2014 May; 15(5):791-806. PubMed ID: 24517173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics in the age of personalized medicine.
    Dickmann LJ; Ware JA
    Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.
    Kapoor R; Tan-Koi WC; Teo YY
    Eur J Hum Genet; 2016 Dec; 24(12):1651-1657. PubMed ID: 27577547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Personalised pharmacotherapy in intensive care unit patients].
    Bellmann R
    Med Klin Intensivmed Notfmed; 2017 May; 112(4):289-294. PubMed ID: 28466289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology.
    Landeck L; Kneip C; Reischl J; Asadullah K
    Exp Dermatol; 2016 May; 25(5):333-9. PubMed ID: 27167702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review).
    Vizirianakis IS; Mystridis GA; Avgoustakis K; Fatouros DG; Spanakis M
    Oncol Rep; 2016 Apr; 35(4):1891-904. PubMed ID: 26781205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine.
    Lambers Heerspink HJ; Oberbauer R; Perco P; Heinzel A; Heinze G; Mayer G; Mayer B
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv105-112. PubMed ID: 26209732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
    Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
    Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics and breast cancer management: current status and perspectives.
    Ciccolini J; Fanciullino R; Serdjebi C; Milano G
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):719-29. PubMed ID: 25690018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics: Principles and Relevance to Oncology Nursing
.
    Dodson CH
    Clin J Oncol Nurs; 2017 Dec; 21(6):739-745. PubMed ID: 29149126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges of pediatric pharmacotherapy: A narrative review of pharmacokinetics, pharmacodynamics, and pharmacogenetics.
    Watanabe H; Nagano N; Tsuji Y; Noto N; Ayusawa M; Morioka I
    Eur J Clin Pharmacol; 2024 Feb; 80(2):203-221. PubMed ID: 38078929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.